Two stomach-originated lactobacillus strains improve Helicobacter pylori infected murine gastritis

World Journal of Gastroenterology

Volumn 16, Issue 4, 2010, Pages 445-452

  Cui, Yi ^a   Wang, Chun Lian ^a   Liu, Xiao Wei ^a   Wang, Xue Hong ^a   Chen, Lin Lin ^a   Zhao, Xin ^a   Fu, Nian ^a   Lu, Fang Gen ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Helicobacter pylori; Lactobacillus acidophilus; Lactobacillus fermenti; Murine gastritis; Therapy

Indexed keywords

ANTIBIOTIC AGENT; FLUORESCENT DYE; PROBIOTIC AGENT; PROTON PUMP INHIBITOR; UREASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CONTROLLED STUDY; FEMALE; GASTRITIS; HELICOBACTER INFECTION; HISTOPATHOLOGY; IN VIVO STUDY; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS FERMENTUM; MALE; MOUSE; NONHUMAN; STOMACH ANTRUM;

EID: 76149085492     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i4.445     Document Type: Article

References (23)

1. Romshoo GJ, Malik GM, Bhat MY, Rather AR, Basu JA, Qureshi KA. Helicobacter pylori associated antral gastritis in peptic ulcer disease patients and normal healthy population of kashmir, India. Diagn Ther Endosc 1998; 4: 135-139
2. Lehours P, Yilmaz O. Epidemiology of Helicobacter pylori infection. Helicobacter 2007; 12 Suppl 1: 1-3
3. Bruce MG, Maaroos HI. Epidemiology of Helicobacter pylori infection. Helicobacter 2008; 13 Suppl 1: 1-6
4. Dubois A, Borén T. Helicobacter pylori is invasive and it may be a facultative intracellular organism. Cell Microbiol 2007; 9: 1108-1116
5. Ziemniak W, Efficacy of Helicobacter pylori eradication taking into account its resistance to antibiotics. J Physiol Pharmacol 2006; 57 Suppl 3: 123-141
6. Silva FM, Eisig JN, Teixeira AC, Barbuti RC, Navarro-Rodriguez T, Mattar R. Short-term triple therapy with azithromycin for Helicobacter pylori eradication: low cost, high compliance, but low efficacy. BMC Gastroenterol 2008; 8: 20
7. Lesbros-Pantoflickova D, Corthésy-Theulaz I, Blum AL. Helicobacter pylori and probiotics. J Nutr 2007; 137: 812S-818S
8. Nolan KJ, McGee DJ, Mitchell HM, Kolesnikow T, Harro JM, O'Rourke J, Wilson JE, Danon SJ, Moss ND, Mobley HL, Lee A. In vivo behavior of a Helicobacter pylori SS1 nixA mutant with reduced urease activity. Infect Immun 2002; 70: 685-691
9. Wang KY, Li SN, Liu CS, Perng DS, Su YC, Wu DC, Jan CM, Lai CH, Wang TN, Wang WM. Effects of ingesting Lactobacillus- and Bifidobacterium- containing yogurt in subjects with colonized Helicobacter pylori. Am J Clin Nutr 2004; 80: 737-741
10. Heczko PB, Strus M, Kochan P. Critical evaluation of probiotic activity of lactic acid bacteria and their effects. J Physiol Pharmacol 2006; 57 Suppl 9: 5-12
11. Johnson-Henry KC, Mitchell DJ, Avitzur Y, Galindo-Mata E, Jones NL, Sherman PM. Probiotics reduce bacterial colonization and gastric inflammation in H. pylori-infected mice. Dig Dis Sci 2004; 49: 1095-1102
12. Ryan KA, Daly P, Li Y, Hooton C, O'Toole PW. Strainspecific inhibition of Helicobacter pylori by Lactobacillus salivarius and other lactobacilli. J Antimicrob Chemother 2008; 61: 831-834
13. Uchida M, Kurakazu K. Yogurt containing Lactobacillus gasseri OLL2716 exerts gastroprotective action against [correction of agaisnt] acute gastric lesion and antral ulcer in rats. J Pharmacol Sci 2004; 96: 84-90
14. Kim MN, Kim N, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Lee DH, Kim JS, Jung HC, Song IS. The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication. Helicobacter 2008; 13: 261-268
15. Valeur N, Engel P, Carbajal N, Connolly E, Ladefoged K. Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Appl Environ Microbiol 2004; 70: 1176-1181
16. Adolfsson O, Meydani SN, Russell RM. Yogurt and gut function. Am J Clin Nutr 2004; 80: 245-256
17. Sýkora J, Valecková K, Amlerová J, Siala K, Dedek P, Watkins S, Varvarovská J, Stozický F, Pazdiora P, Schwarz J. Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 and the eradication of H. pylori in children: a prospective randomized double-blind study. J Clin Gastroenterol 2005; 39: 692-698
18. Tan MP, Kaparakis M, Galic M, Pedersen J, Pearse M, Wijburg OL, Janssen PH, Strugnell RA. Chronic Helicobacter pylori infection does not significantly alter the microbiota of the murine stomach. Appl Environ Microbiol 2007; 73: 1010-1013
19. Sgouras DN, Panayotopoulou EG, Martinez-Gonzalez B, Petraki K, Michopoulos S, Mentis A. Lactobacillus johnsonii La1 attenuates Helicobacter pylori-associated gastritis and reduces levels of proinflammatory chemokines in C57BL/6 mice. Clin Diagn Lab Immunol 2005; 12: 1378-1386
20. Coconnier MH, Lievin V, Hemery E, Servin AL. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl Environ Microbiol 1998; 64: 4573-4580
21. Sgouras D, Maragkoudakis P, Petraki K, Martinez-Gonzalez B, Eriotou E, Michopoulos S, Kalantzopoulos G, Tsakalidou E, Mentis A. In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Appl Environ Microbiol 2004; 70: 518-526
22. Sutton P, Danon SJ, Walker M, Thompson LJ, Wilson J, Kosaka T, Lee A. Post-immunisation gastritis and Helicobacter infection in the mouse: a long term study. Gut 2001; 49: 467-473
23. Tam YH, Yeung CK, Lee KH, Sihoe JD, Chan KW, Cheung ST, Mou JW. A population-based study of Helicobacter pylori infection in Chinese children resident in Hong Kong: prevalence and potential risk factors. Helicobacter 2008; 13: 219-224